These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy. Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094 [TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicles Carrying miR-887-3p Promote Breast Cancer Cell Drug Resistance by Targeting BTBD7 and Activating the Notch1/Hes1 Signaling Pathway. Wang B; Wang Y; Wang X; Gu J; Wu W; Wu H; Wang Q; Zhou D Dis Markers; 2022; 2022():5762686. PubMed ID: 35655918 [TBL] [Abstract][Full Text] [Related]
7. EGCG inhibits the inflammation and senescence inducing properties of MDA-MB-231 triple-negative breast cancer (TNBC) cells-derived extracellular vesicles in human adipose-derived mesenchymal stem cells. Gonzalez Suarez N; Fernandez-Marrero Y; Hébert MPA; Roy ME; Boudreau LH; Annabi B Cancer Cell Int; 2023 Oct; 23(1):240. PubMed ID: 37833751 [TBL] [Abstract][Full Text] [Related]
8. Stem cell-derived extracellular vesicles reduce the expression of molecules involved in cardiac hypertrophy-In a model of human-induced pluripotent stem cell-derived cardiomyocytes. Constantin A; Comarița IK; Alexandru N; Filippi A; Bojin F; Gherghiceanu M; Vîlcu A; Nemecz M; Niculescu LS; Păunescu V; Georgescu A Front Pharmacol; 2022; 13():1003684. PubMed ID: 36299891 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target. Koni M; Castellano I; Venturelli E; Sarcinella A; Lopatina T; Grange C; Cedrino M; Femminò S; Cossu-Rocca P; Orrù S; D'Ascenzo F; Cotellessa I; Tampieri C; Debernardi C; Cugliari G; Matullo G; Camussi G; De Miglio MR; Brizzi MF Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010912 [TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles from human liver stem cells inhibit tumor angiogenesis. Lopatina T; Grange C; Fonsato V; Tapparo M; Brossa A; Fallo S; Pitino A; Herrera-Sanchez MB; Kholia S; Camussi G; Bussolati B Int J Cancer; 2019 Jan; 144(2):322-333. PubMed ID: 30110127 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-370-3p shuttled by breast cancer cell-derived extracellular vesicles induces fibroblast activation through the CYLD/Nf-κB axis to promote breast cancer progression. Ren Z; Lv M; Yu Q; Bao J; Lou K; Li X FASEB J; 2021 Mar; 35(3):e21383. PubMed ID: 33629796 [TBL] [Abstract][Full Text] [Related]
12. Extracellular Vesicles Released by Tumor Endothelial Cells Spread Immunosuppressive and Transforming Signals Through Various Recipient Cells. Lopatina T; Favaro E; Danilova L; Fertig EJ; Favorov AV; Kagohara LT; Martone T; Bussolati B; Romagnoli R; Albera R; Pecorari G; Brizzi MF; Camussi G; Gaykalova DA Front Cell Dev Biol; 2020; 8():698. PubMed ID: 33015029 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2. Liu H; Wang G Exp Ther Med; 2021 Sep; 22(3):945. PubMed ID: 34306209 [TBL] [Abstract][Full Text] [Related]
14. miR-21-5p in extracellular vesicles obtained from adipose tissue-derived stromal cells facilitates tubular epithelial cell repair in acute kidney injury. Bian Z; Wang X; Zhu R; Chen S Cytotherapy; 2023 Mar; 25(3):310-322. PubMed ID: 36244909 [TBL] [Abstract][Full Text] [Related]
15. Breast cancer cell-derived extracellular vesicles transfer miR-182-5p and promote breast carcinogenesis via the CMTM7/EGFR/AKT axis. Lu C; Zhao Y; Wang J; Shi W; Dong F; Xin Y; Zhao X; Liu C Mol Med; 2021 Jul; 27(1):78. PubMed ID: 34294040 [TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicle-Mediated Purinergic Signaling Contributes to Host Microenvironment Plasticity and Metastasis in Triple Negative Breast Cancer. Duan S; Nordmeier S; Byrnes AE; Buxton ILO Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435297 [TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma. Zhang K; Dong C; Chen M; Yang T; Wang X; Gao Y; Wang L; Wen Y; Chen G; Wang X; Yu X; Zhang Y; Wang P; Shang M; Han K; Zhou Y Theranostics; 2020; 10(1):411-425. PubMed ID: 31903129 [No Abstract] [Full Text] [Related]
18. Human bone marrow mesenchymal stem cell-derived extracellular vesicles reduce inflammation and pyroptosis in acute kidney injury via miR-223-3p/HDAC2/SNRK. Xie Z; Tang J; Chen Z; Wei L; Chen J; Liu Q Inflamm Res; 2023 Mar; 72(3):553-576. PubMed ID: 36640195 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Attenuate Dendritic Cell Maturation and Function. Reis M; Mavin E; Nicholson L; Green K; Dickinson AM; Wang XN Front Immunol; 2018; 9():2538. PubMed ID: 30473695 [TBL] [Abstract][Full Text] [Related]
20. MECHANISM OF MIR-25-3P CARRIED BY EXTRACELLULAR VESICLES DERIVED FROM PLATELET-RICH PLASMA IN IL-1β-INDUCED NUCLEUS PULPOSUS CELL DEGENERATION VIA THE SOX4/CXCR7 AXIS. Hu B; Wang L; Sun N; Lin S; Rui G Shock; 2022 Jul; 58(1):56-67. PubMed ID: 35984761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]